Anika Therapeutics Remains On Course In Transition Year

By Mike Evers

Anika Therapeutics Remains On Course In Transition Year
The company benefitted from improving COVID conditions in 2Q21 and remains on course to achieve both short and long-term strategic goals.

Member-Only Content

SUBSCRIBE Login

Product Labels: Shoulder Replacement, Finger/Hand/Wrist Replacement, Viscosupplement

Tags: Revenue Report